Cognitive Remediation in 22q11DS

22q11.2 Deletion Syndrome Clinical Trial

Official title: A Remediation Program for Children at High-Risk of Schizophrenia: 22q11.2 Deletion Syndrome

Status Completed

Clinical Trial Summary

The goal of this study is to collect preliminary data on the efficacy of a cognitive remediation program in improving the neurocognitive deficits in children with chromosome 22q11.2 deletion syndrome (22q11DS). This study involves a two part approaching including a computerized cognitive remediation program (CCRP, Posit Science, CA) in combination with a Social Cognitive Training (SCT) program. The computer-based training program has shown encouraging results in improving learning deficits in individuals with schizophrenia and we now seek to adapt them to children with 22q11DS, who have unique needs due to their lower IQ and high risk of psychosis in late adolescence and adulthood. The SCT is a small-group intervention program based on cognitive enhancement therapy, which has been shown to improve social cognition and functionality in adults with schizophrenia. A preliminary study will be performed using this two-pronged approach, to establish the feasibility and gather preliminary data on neurocognition before and after the intervention in these children; these data would enable a larger randomized controlled study to assess the efficacy of this approach.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label

Related Conditions & MeSH terms

• 22q11.2 Deletion Syndrome
• DiGeorge Syndrome
• Facial Paralysis
• Syndrome
• Velo-Cardio-Facial Syndrome

• NCT number: NCT01781923
• Study type: Interventional
• Source: Duke University
• Status: Completed
• Phase: N/A
• Start date: October 2010
• Completion date: June 2015